GEISTWERT Rechtsanwälte Lawyers Avvocati

ORD_11300/2025

Samsung Bioepis NL B.V. v. Alexion Pharmaceuticals, Inc.

Date
2025-08-01
Division
Hamburg (DE) Local Division
Type of action
Application For Costs
Language
EN

Metadata

Case IDORD_11300-2025-ace1fdb40eb2
Case number
Registry numberORD_11300/2025
Order referenceORD_11300/2025
Keywords
Headnotes

Documents and full text

Extractor: pypdf | Pages: 11

Local division Hamburg UPC_CFI_40/2025 ACT_3177/2025 Decision of the Court of First Instance of the Unified Patent Court Local Division Hamburg issued on 1 August 2025 APPLICANT: Alexion Pharmaceuticals, Inc., 121 Seaport Boulevard, Boston, MA 02210, USA, represented by: Elena Hennecke, Freshfields PartG mbB, Feldmühleplatz 1, 40545 Düsseldorf DEFENDANT: Samsung Bioepis NL B.V., Olof Palmestraat 10, 2616 LR Delft, Netherlands, represented by: Andrea Ritter, Simmons & Simmons LLP, Kö-Bogen, Königsallee 2a, 40212 Düsseldorf PATENT AT ISSUE European Patent n° EP 3 167 888 PANEL/DIVISION Panel of the Local Division Hamburg DECIDING JUDGE/S This decision has been delivered by the judge-rapporteur Sabine Klepsch. 2 LANGUAGE OF THE PROCEEDINGS English SUBJECT-MATTER OF THE PROCEEDINGS Application ...